Results 131 to 140 of about 3,074 (177)

Editorial: Genetic underpinnings of Alzheimer's and Parkinson's: insights and innovations. [PDF]

Front Genet
Marongiu R, Cordato D, Reiss AB.
europepmc   +1 more source

Plasma Levels of Food-Derived Metabolites as Biomarkers of Parkinson's Disease. [PDF]

Int J Mol Sci
Dong X, Zheng Y, Tan ETY, Sun QY, Xiao B, Tan EK, Wu YC, Zhou ZD.   +7 more
europepmc   +1 more source

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant. [PDF]

Mov Disord Clin Pract
Kamo H, Oyama G, Shimizu M, Takeshige-Amano H, Ogawa T, Sako W, Nishikawa N, Hatano T, Li Y, Yoshino H, Funayama M, Ito M, Iwamuro H, Umemura A, Hattori N.   +14 more
europepmc   +1 more source

Longitudinal Evaluation of Neurological and Sensory Changes in Gaucher Disease: A Prospective Observational Cohort Study (SENOPRO). [PDF]

Med Sci (Basel)
Cerulli Irelli E, Mazzeo A, Fallarino N, Caramia F, Tessari G, Morgillo E, Di Bonaventura C, Turchetta R, Palumbo G, Tullo MG, Mariani L, Nebbioso M, Mancini P, Guariglia C, Giona F.   +14 more
europepmc   +1 more source

RETRACTED: A systematic genomic screen of 755 early-onset Parkinson’s patients from the 100,000 Genomes Project increases diagnostic yield and directs clinical pathways

Newbury DF, Sabu N, Hussein ESH, Taylor JC.   +3 more
europepmc   +1 more source

Dairy-rich diet triggers hepatic α-synuclein pathology via the liver-brain axis in GBA1-related Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Chen Y, Ma M, Zhang R, Guo C, Ding X, Wang J, Qin C, Feng R, Meng H, Wu H, Que W, Wang X, Tang B.   +12 more
europepmc   +1 more source

Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease-Associated Parkinsonism: Insights Into a Potential Therapeutic Target. [PDF]

J Cell Mol Med
Ardizzone A, Lanza M, Capra AP, Casili G, Bulzomì M, Luca F, Paterniti I, Campolo M, Esposito E.   +8 more
europepmc   +1 more source

The c-Abl-RIPK3 Axis Drives Mitochondrial Dysfunction and Impaired Mitophagy in Gaucher Disease Models. [PDF]

Antioxidants (Basel)
Lamaizon CM, Tironi-Hernández R, Arévalo NB, Ahumada SD, Gutiérrez DA, Brito-Fernández L, Del Campo A, Zanlungo S, Álvarez AR.   +8 more
europepmc   +1 more source

Clinical and genetic predictors of dementia in Parkinson’s disease

Solomons MR, Hannaway N, Fox O, Costantini A, Real R, Zarkali A, Morris HR, Weil RS, the Vision in Parkinson’s Study team.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Classification of GBA1 variants in Parkinson’s disease; the GBA1 -PD browser

2022
ABSTRACT Background GBA1 variants are among the most common genetic risk factors for Parkinson’s Disease (PD). GBA1 variants can be classified into three categories based on their role in Gaucher’s Disease (GD) or PD ...
Sitki Cem, Parlar, Francis P, Grenn, Jonggeol Jeffrey, Kim, Cornelis, Baluwendraat, Ziv, Gan-Or   +4 more
openaire   +2 more sources